Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

VK expects to increase the number of cryptocurrency wallets in VK NFT to 1 million

3/24/23 VKCO

Whoosh opened the season in Moscow and other cities

3/24/23 WUSH

Beluga Group's RAS profit in 2022 increased by 7.6%

3/24/23 BELU

Rosseti Siberia reported its 2022 IFRS results

3/24/23 MRKS

Italy's Marcegaglia wants to buy Severstal's EU unit

3/24/23 CHMF

INARCTICA acquired a fish hatchery in the Nizhny Novgorod region

3/24/23 AQUA

VK introduces new tools for media content creation

3/24/23 VKCO

Vladimir Putin demanded allocation of up to ₽20 billion for wooden houses

3/24/23 SGZH

Bank Saint-Petersburg reported for 2022 according to RAS

3/24/23 BSPB

Board of Directors of Bank St. Petersburg recommended that dividends be paid for 2022

3/23/23 BSPB